Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 112 Records) |
Query Trace: Small Cell Lung Carcinoma and EGFR[original query] |
---|
Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum. Cureus 2021 Jul 13 (7): e16195. Laishram Devina, Raphael Vandana, Marbaniang Evarisalin, Harris Caleb, Jagtap Vikas, Wankhar Baphiraly |
How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review. Critical reviews in oncology/hematology 2021 8 166 103459. Torres Gabriel Fernando, Bonilla Carlos Eduardo, Buitrago Giancarlo, Arrieta Oscar, Malapelle Umberto, Rolfo Christian, Cardona Andrés |
Rare epidermal growth factor receptor gene alterations in non-small cell lung cancer patients, tyrosine kinase inhibitor response and outcome analysis. Cancer treatment and research communications 2021 5 28 100398. Mehta Anurag, Vasudevan Smre |
Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study. Frontiers in molecular biosciences 2021 5 8 639892. Yang Xue, Xia Yang, Xu Liyan, Liang Li, Zhuo Minglei, Wu Meina, An Tongtong, Wang Ziping, Wang Yuyan, Li Jianjie, Zhong Jia, Chen Hanxiao, Jia Bo, Wang Jingjing, Zhao J |
Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 12 35 (5): 615-624. Shepherd Daniel J, Tabb Elisabeth S, Kunitoki Keiko, Zhang M Lisa, Kem Marina, Barth Jaimie, Qualls David A, Mooradian Meghan J, Gainor Justin F, Mino-Kenudson Mari, Hung Yin |
Frequency of Epidermal Growth Factor Receptor and T790M Mutations Among Patients With Non-Small Cell Lung Carcinoma: A Hospital-Based Study in the King Khalid University Hospital (KKUH) Since 2009-2017. Cureus 2021 12 13 (11): e19816. AlQahtani Sara H, AlOgaiel Areeb M, AlMosa Kowthar N, Alenazi Suha H, AlHasan Monira K, AlObaidan Reham H, Aldokheel Bayan D, AlSaleh Khalid, Arafah Maha, Ali Khan Imran, AlOtaiby Mar |
Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma. Journal of pathology and translational medicine 2021 07 . Nakra Tripti, Singh Varsha, Nambirajan Aruna, Malik Prabhat Singh, Mohan Anant, Jain Deepa |
Two missense variants of the epidermal growth factor receptor gene are associated with non small cell lung carcinoma in the subjects from Iraq. Molecular biology reports 2022 9 49 (12): 11653-11661. Lawi Zahraa K, Al-Shuhaib Mohammed Baqur S, Amara Ibtissem Ben, Alkhammas Ahmed |
Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma. Genes 2022 8 13 (8): . Abdelmaksoud-Dammak Rania, Ammous-Boukhris Nihel, Saadallah-Kallel Amèna, Charfi Slim, Khemiri Souhir, Khemakhem Rim, Kallel Nesrin, Ben Kridis-Rejeb Wala, Sallemi-Boudawara Tahya, Khanfir Afef, Yangui Ilhem, Daoud Jamel, Mokdad-Gargouri Ra |
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort. Journal of thoracic disease 2022 Jun 14 (6): 2034-2044. Tankere Pierre, Boidot Romain, Bonniaud Philippe, Zouak Ayoube, Foucher Pascal, Milliere Alice, Bertaut Aurélie, Favier Laure, Lagrange Aurélie, Ghiringhelli François, Kaderbhai Courèche Guillaume, Fraisse Cl |
Clinical value of alveolar lavage supernatant specimens in the detection of the EGFR gene mutation in patients with non-small cell lung carcinoma. Translational cancer research 2022 6 11 (5): 1188-1194. Han Songyan, Guo Yanrong, Luo Xinwei, Tong Guoping, Zhao Chang, Li Yuan, Guo Tingting, Wang Li, Gao Ning, Liu Yuexiang, Li Hongwei, Yang Weih |
The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt. Journal of the Egyptian National Cancer Institute 2022 6 34 (1): 23. Bahnassy Abeer A, Ismail Hoda, Mohanad Marwa, El-Bastawisy Ahmed, Yousef Hend |
Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection. Indian journal of pathology & microbiology 2022 4 65 (2): 296-304. Shukla Saumya, Pandey Rahul K, Mishra Sridhar, Tripathi Suryakant, Garg Rajiv, Gupta Gaurav, Husain Nuzh |
A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma. Translational lung cancer research 2022 3 11 (2): 238-249. Chen Ying, Xu Jinhe, Zhang Lei, Song Yingfang, Wen Wen, Lu Jun, Zhao Zhongquan, Kong Wencui, Liu Wei, Guo Aiping, Santarpia Mariacarmela, Yamada Tadaaki, Cai Xiuyu, Yu Zongya |
A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2022 3 166 (3): 274-279. Hwang Cheng-Cheng, Hsieh Tsan-Yu, Yeh Kun-Yang, Chen Tzu-Ping, Hua Chung-Ching, Chang Liang-Che, Chen Jim-R |
Acute fulminant hepatitis associated with osimertinib administration in a lung cancer patient with chronic hepatitis B: The first mortality case report. Thoracic cancer 2022 2 13 (7): 1091-1094. Kang You-Kuang, Meng Fan-Ch |
Interpretation of Lung Cancer Plasma EGFR Mutation Tests in the Clinical Setting. American journal of clinical pathology 2022 12 159 (2): 181-191. Cheung Alvin Ho-Kwan, Wong Kit-Yee, Chiang Cho-Han, Liu Xiaoli, Zhang Yihan, Hui Chris Ho-Lam, Chen Bonan, Wang Yifei, Chow Chit, Kang Wei, To Ka-F |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
Durable response to durvalumab-based immunochemotherapy in small-cell lung carcinoma transformation from EGFR-mutant non-small cell lung cancer: A case report. Thoracic cancer 2022 1 13 (5): 775-779. Li Yu-Chu |
Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: evidence from a case series of non-squamous, non-small cell lung cancer (NSCLC) patients with follow-up. Journal of clinical pathology 2022 Jan . Finall Alison, Davies Gareth, Jones Trevor, Emlyn Gwion, Huey Pearl, Mullard An |
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery. Cancers 2023 9 15 (17): . Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Ch |
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines 2023 9 11 (9): . Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, Ryotaro Igusa, Hayato Yokota, Kana Watanabe, Aya Suzuki, Mami Morita, Ren Onodera, Akira Inoue, Masatomo Miura, Yoshihiro Minamiya, Makoto Maemon |
Association of PD-L1 tumor proportion score ?20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer medicine 2023 8 . Yusuke Hamakawa, Yoko Agemi, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yukiko Nakamura, Tsuneo Shimokawa, Yusuke Saigusa, Nobuaki Kobayashi, Hiroaki Okamoto, Takeshi Kane |
Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis. Journal of magnetic resonance imaging : JMRI 2023 5 . Ying Fan, Xinti Wang, Chunna Yang, Huanhuan Chen, Huan Wang, Xiaoyu Wang, Shaoping Hou, Lihua Wang, Yahong Luo, Xianzheng Sha, Huazhe Yang, Tao Yu, Xiran Jia |
Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations. Internal medicine (Tokyo, Japan) 2023 4 . Masafumi Shimoda, Yoshiaki Tanaka, Kozo Morimoto, Kozo Yoshimori, Ken Oh |
EGFR Mutation in Non-squamous Non-small-cell Lung Carcinoma (NS-NSCLC) in the Arab World: A systematic Review. The Gulf journal of oncology 2023 2 1 (41): 54-61. Nassar Dany, Chidiac Claudia, Ibrahim Elio, Abou Zeid Karl, Haddad Fady, Kourie Hamp |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma-An Indian Perspective of 212 Patients. International journal of environmental research and public health 2023 1 20 (1): . Kaler Amrit Kaur, Patel Khushi, Patil Harshali, Tiwarekar Yash, Kulkarni Bijal, Hastak Meenal, Athikari Nivetha, Rane Samrudhi, Nikam Ankita, Umarji Smita, Shaikh Imran, Goyle Sandeep, Mistry Raje |
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma. Journal of translational medicine 2024 1 22 (1): 87. Jie Peng, Dan Zou, Xudong Zhang, Honglian Ma, Lijie Han, Biao Y |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: